Validation of a low-cost, liquid-based screening method for cervical intraepithelial neoplasia

American Journal of Obstetrics and Gynecology

Volumn 195, Issue 4, 2006, Pages 965-970

  Lee, Judy M ^a   Kelly, Deidra ^b   Gravitt, Patti E ^c   Fansler, Zoya ^b   Maksem, John A ^d   Clark, Douglas P ^b  

^a Department of Gynecology and Obstetrics   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d BOSTWICK LABORATORIES   (United States)

Author keywords

Cervical cancer screening; Liquid based cytology; Low cost

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CYTOCHEMISTRY; CYTOLOGY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METHODOLOGY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STANDARDIZATION; UTERINE CERVIX CARCINOMA IN SITU; VALIDATION PROCESS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTODIAGNOSIS; FEMALE; HEALTH CARE COSTS; HIV SEROPOSITIVITY; HUMANS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33748807244     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.02.001     Document Type: Article

References (19)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Marte C., Kelly P., Cohen M., Fruchter R.G., Sedlis A., Gallo L., et al. Papanicolaou smear abnormalities in ambulatory care sites for women infected with the human immunodeficiency virus. Am J Obstet Gynecol 166 (1992) 1232-1237
3. Wright Jr. T.C., Ellerbrock T.V., Chiasson M.A., Van Devanter N., and Sun X.W. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study. Obstet Gynecol 84 (1994) 591-597
4. Schuman P., Ohmit S.E., Klein R.S., Duerr A., Cu-Uvin S., Jamieson D.J., et al. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis 188 (2003) 128-136
5. Massad L.S., Seaberg E.C., Watts D.H., Hessol N.A., Melnick S., Bitterman P., et al. Low incidence of invasive cervical cancer among HIV-infected U.S. women in a prevention program. AIDS 18 (2004) 109-113
6. Soost H.J., Lange H.J., Lehmacher W., and Ruffing-Kullmann B. The validation of cervical cytology. Sensitivity, specificity and predictive values. Acta Cytol 35 (1991) 8-14
7. Sprenger E., Schwarzmann P., Kirkpatrick M., Fox W., Heinzerling R.H., Geyer J.W., et al. The false negative rate in cervical cytology. Comparison of monolayers to conventional smears. Acta Cytol 40 (1996) 81-89
8. Hutchinson M.L., Zahniser D.J., Sherman M.E., Herrero R., Alfaro M., Bratti M.C., et al. Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma. Cancer 87 (1999) 48-55
9. Johnson T., Maksem J.A., Belsheim B.L., Roose E.B., Klock L.A., and Eatwell L. Liquid-based cervical-cell collection with brushes and wooden spatulas: a comparison of 100 conventional smears from high-risk women to liquid-fixed cytocentrifuge slides, demonstrating a cost-effective, alternative monolayer slide preparation method. Diagn Cytopathol 22 (2000) 86-91
10. Inside the diagnostics industry. Washington, DC: April 2005. Available from: www.g2reports.com.
11. Maksem J.A., Finnemore M., Belsheim B.L., Roose E.B., Makkapati S.R., Eatwell L., et al. Manual method for liquid-based cytology: a demonstration using 1,000 gynecological cytologies collected directly to vial and prepared by a smear-slide technique. Diagn Cytopathol 25 (2001) 334-338
12. Lazcano-Ponce E.C., Alonso de Ruiz P., Lopez-Carrillo L., Najera-Aguilar P., Avila-Ceniceros R., Escandon-Romero C., et al. Validity and reproducibility of cytologic diagnosis in a sample of cervical cancer screening centers in Mexico. Acta Cytol 41 (1997) 277-284
13. Carpenter A.B., and Davey D.D. ThinPrep Pap test: performance and biopsy follow-up in a university hospital. Cancer 87 (1999) 105-112
14. Baker J.J. Conventional and liquid-based cervicovaginal cytology: a comparison study with clinical and histologic follow-up. Diagn Cytopathol 27 (2002) 185-188
15. Abulafia O., Pezzullo J.C., and Sherer D.M. Performance of ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: a quantitative survey. Gynecol Oncol 90 (2003) 137-144
16. Montz F.J., Farber F.L., Bristow R.E., and Cornelison T. Impact of increasing Papanicolaou test sensitivity and compliance: a modeled cost and outcomes analysis. Obstet Gynecol 97 5 Pt 1 (2001) 781-788
17. Neville A.M., and Quinn M.A. An alternative cost effectiveness analysis of ThinPrep in the Australian setting. Aust N Z J Obstet Gynaecol 45 (2005) 289-294
18. Goldie S.J., Gaffikin L., Goldhaber-Fiebert J.D., Gordillo-Tobar A., Levin C., Mahe C., et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 353 (2005) 2158-2168
19. Schiffman M., and Castle P.E. The promise of global cervical-cancer prevention. N Engl J Med 353 (2005) 2101-2104